Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Church who wrote (596)	4/12/1997 7:32:00 AM
From: Pete Holm	of 6136

Can anyone verify the following? All of the cost comparisons I've seen are based on the Average Wholesale Price (i.e. the manufacturer's price plus 16 2/3%). This is normally a good comparison and usually works out to what the patient pays.. I heard that Merck ships all of its Crixivan to a company called Statlanders. This company puts a 37% upcharge on the product to place it into the wholesale system. If this is true, then the actual patient cost is 21-37% higher than previously quoted. This might also mean that Viracept is the lowest priced PI to the patient. So, Does anyone know more about Merck's supply system? Can someone do some price shopping at a large chain store (like Walgreen's) and a small independent pharmacy (like in a clinic), and find out the actual patient cost comparison between the two? thecure.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next